Summary
Updated Aug 30, 2026
Rachel McMinn is Chief Executive Officer, Director of Neurogene Inc. (NGNE). 3 SEC Form 4 filings on record going back to 2024, most recently on 30 March 2026. Most recent open-market trade: sold $74K of NGNE on 30 March 2026. Lifetime open-market purchases: $969K. Lifetime open-market sales: $74K.
Recent Transactions
3Every recent SEC Form 4 transaction Rachel McMinn has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Rachel McMinn go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. The typical open-market purchase is $969K (1 buy totaling $969K). The largest single buy on record is $969K of NGNE in 2024. Sales side: 1 recorded sale totaling $74K, so the filing history runs buy-heavy by dollar value. 1 recorded transaction carries a Rule 10b5-1 flag, meaning it was pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Rachel McMinn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Mikail Cvijic - $900K of NGNE open-market activity in the last 12 months
- Stuart Cobb - $141K of NGNE open-market activity in the last 12 months
- Julie Jordan - $18K of NGNE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Rachel McMinn?
Rachel McMinn is a corporate insider, tracked as Chief Executive Officer, Director of Neurogene Inc. (NGNE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Rachel McMinn last file a Form 4?
The most recent primary Form 4 on record is dated 30 March 2026, one of 3 filings going back to 2024.
Has Rachel McMinn been buying or selling stock?
Recorded transactions: 1 open-market purchase ($969K) and 1 open-market sale ($74K) across all tracked filings.
Where can I see all of Rachel McMinn's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Rachel McMinn and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial